Publications

Immune responses to Sinopharm/BBIBP-CorV in individuals in Sri Lanka.

Jeewandara C. et al, (2022), Immunology

T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles.

Céspedes PF. et al, (2022), Nat Commun, 13

COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records.

Thygesen JH. et al, (2022), Lancet Digit Health

Persistence of immune responses to the Sinopharm/BBIBP-CorV vaccine.

Jeewandara C. et al, (2022), Immun Inflamm Dis, 10

A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design.

Zhang H. et al, (2022), BMC Immunol, 23

Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals.

Jeewandara C. et al, (2022), Immun Inflamm Dis, 10

The bacteriology of pleural infection (TORPIDS): an exploratory metagenomics analysis through next generation sequencing

Kanellakis NI. et al, (2022), The Lancet Microbe, 3, e294 - e302

SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.

Guo L. et al, (2022), Lancet Microbe

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.

COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk None. and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None., (2022), Cell, 185, 916 - 938.e58

Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac).

Jeewandara C. et al, (2022), Sci Rep, 12

An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease.

Peng Y. et al, (2021), Nat Immunol

Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals.

Jeewandara C. et al, (2021), medRxiv

Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals.

Jeewandara C. et al, (2021), medRxiv

Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.

Evans RA. et al, (2021), Lancet Respir Med

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV.

Alrubayyi A. et al, (2021), Nat Commun, 12

Immunodominance complexity: lessons yet to be learned from dominant T cell responses to SARS-COV-2

Wellington D. et al, (2021), Current Opinion in Virology, 50, 183 - 191

The impact of viral mutations on recognition by SARS-CoV-2 specific T-cells

de Silva TI. et al, (2021), iScience, 103353 - 103353

Association between circulating CD39+CD8+ T cells pre-chemoradiotherapy and prognosis in patients with nasopharyngeal carcinoma.

Dong D-N. et al, (2021), Chin Med J (Engl)

Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages

DONG TAO. et al, (2021), BMC Cancer

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.

Skelly DT. et al, (2021), Nat Commun, 12

Cookies on this website